{
  "HL7 Standard": {
    "summary": "This IG is fundamentally built upon FHIR to enable the translation of data from various Common Data Models (CDMs) into a standardized FHIR format. It heavily relies on FHIR resources, profiles, and extensions, particularly leveraging US-Core. While it acknowledges other HL7 standards, its core functionality is solely based on FHIR, with no direct interaction or dependency on CDA, v2, or v3.",
    "scores": {
      "CDA": 0,
      "Cross-Paradigm": 0.2,
      "FHIR": 1,
      "v2": 0,
      "v3": 0
    }
  },
  "Geographic Scope": {
    "summary": "The CDMH FHIR IG leverages US-Core profiles and is relevant to the US data infrastructure, indicating a strong national focus. It is a multi-agency collaboration led by the FDA and involving other US agencies. Therefore, it is classified as a National Implementation Guide for the United States.",
    "scores": {
      "Universal Realm": 0,
      "National > United States": 1,
      "Regional": 0
    }
  },
  "Domain Focus": {
    "summary": "The CDMH FHIR IG focuses on translating observational data from four different Common Data Models (CDMs) into a standardized FHIR format, primarily for research purposes. It leverages US-Core profiles and defines a \"Result Translator\" actor to facilitate this translation. While it touches upon clinical data and workflow aspects related to querying and data retrieval, its core purpose is to enable interoperability and data sharing among research networks.",
    "scores": {
      "Administrative": 0.2,
      "Care Planning": 0,
      "Clinical Data": 0.8,
      "Clinical Knowledge": 0.2,
      "Diagnostics": 0.2,
      "Identity & Security": 0.2,
      "Insurance, Payment & Financial": 0,
      "Medications": 0.2,
      "Public Health": 0.4,
      "Quality & Reporting": 0.2,
      "Research": 1,
      "Workflow": 0.6
    }
  },
  "Implementers": {
    "summary": "The CDMH FHIR IG focuses on enabling interoperability between research networks using different Common Data Models (CDMs) by translating their data into FHIR. It primarily targets research platforms and systems involved in managing and analyzing clinical research data. While EHRs are indirectly involved as the source of data populating the CDMs, the IG does not mandate direct EHR integration. The IG has minimal relevance to clinical decision support, imaging, lab, payer, pharmacy, PHR, and public health systems in its current scope.",
    "scores": {
      "Clinical Decision Support": 0,
      "EHR Systems": 0.4,
      "Imaging Systems": 0,
      "Lab Systems": 0,
      "Payer Systems": 0,
      "Pharmacy Systems": 0,
      "PHR Systems": 0,
      "Public Health Systems": 0.2,
      "Research Platforms": 1
    }
  },
  "Users & Stakeholders": {
    "summary": "This FHIR Implementation Guide (IG) focuses on enabling interoperability between different research networks using Common Data Models (CDMs) by translating their data into a standardized FHIR format. The primary users are researchers who need to query and analyze data from these networks. The IG heavily relies on existing standards like US-Core and is driven by the needs of research organizations and government agencies involved in public health and regulatory oversight.",
    "scores": {
      "Clinical Care Teams": 0.2,
      "Healthcare Administrators": 0.4,
      "Patients and Caregivers": 0.2,
      "Payers": 0,
      "Public Health Agencies": 0.8,
      "Research Organizations": 1,
      "Government Agencies": 0.8
    }
  },
  "meta": {
    "model": "gemini-exp-1206",
    "generation_config": {
      "temperature": 0
    },
    "workerCount": 3
  }
}